214 related articles for article (PubMed ID: 31897189)
1. T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy.
Wang X; Xu Y; Guo S; Zhang J; Abe M; Tan H; Wang S; Chen P; Zong L
Oncol Lett; 2020 Jan; 19(1):735-744. PubMed ID: 31897189
[TBL] [Abstract][Full Text] [Related]
2. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Xia LY; Xu WY; Zhao Y
PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
[TBL] [Abstract][Full Text] [Related]
3. Post-mastectomy Radiotherapy in T1-2 Breast Cancer Patients With One to Three Lymph Node Metastases: A Propensity Score Matching Analysis.
Chen M; Huang Y; Leng Z; Yang G; Li F; Yang H; Hou L
Front Oncol; 2019; 9():1551. PubMed ID: 32117784
[No Abstract] [Full Text] [Related]
4. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database.
Wang J; Zhang WW; Lian CL; Sun JY; He ZY; Wu SG
Front Oncol; 2019; 9():747. PubMed ID: 31475106
[No Abstract] [Full Text] [Related]
6. The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
Zhang L; Tang R; Deng JP; Zhang WW; Lin HX; Wu SG; He ZY
BMC Cancer; 2020 Nov; 20(1):1146. PubMed ID: 33238939
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.
Hu J; Tan J; Dong F; Zhang X; Ming J; Huang T
Front Oncol; 2021; 11():593121. PubMed ID: 35096554
[TBL] [Abstract][Full Text] [Related]
8. Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method.
Ye S; Hu W
Medicine (Baltimore); 2022 Sep; 101(37):e30610. PubMed ID: 36123865
[TBL] [Abstract][Full Text] [Related]
9. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
Zhang WW; Tong Q; Sun JY; Hua X; Long ZQ; Deng JP; Dong Y; Li FY; He ZY; Wu SG; Lin HX
Front Oncol; 2019; 9():270. PubMed ID: 31041190
[No Abstract] [Full Text] [Related]
10. The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database.
Lin J; Luo S; Zhang J; Song C
BMC Geriatr; 2023 Oct; 23(1):625. PubMed ID: 37803254
[TBL] [Abstract][Full Text] [Related]
11. The Effect of HER2 Status on Metaplastic Breast Cancer A Propensity Score-Matched Analysis.
Hu J; Zhang Y; Dong F; Shen J; Chen H; Li L; Huang T
Front Endocrinol (Lausanne); 2022; 13():874815. PubMed ID: 35928894
[TBL] [Abstract][Full Text] [Related]
12. Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
Wang Q; Zhao J; Han X; Er P; Meng X; Shi J; Sun H; Zhu J; Zhu L; Wu S; Zhang W; Sun B
Front Oncol; 2020; 10():892. PubMed ID: 32695661
[No Abstract] [Full Text] [Related]
13. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
14. Benefits of post-mastectomy radiation for T4N0M0 breast cancer patients: A SEER Database study.
Zhao R; He W; Guan X
Cancer Treat Res Commun; 2022; 32():100586. PubMed ID: 35691256
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the benefit of post-mastectomy radiotherapy in patients with early-stage breast cancer: A propensity score matching study.
Shi W; Luo Y; Zhao D; Huang H; Pang W
Oncol Lett; 2019 Jun; 17(6):4851-4858. PubMed ID: 31186692
[TBL] [Abstract][Full Text] [Related]
16. The Value of the 8th Edition of American Joint Committee on Cancer Pathological Prognostic Staging on the Selection of Postmastectomy Radiotherapy for T1-2N1 Breast Cancer.
Wang J; Zhong XR; Luo T; Xiang ZZ; Zeng YY; Yang T; Zheng H; Liu L
J Oncol; 2022; 2022():7550323. PubMed ID: 36330354
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy after mastectomy has significant survival benefits for inflammatory breast cancer: a SEER population-based retrospective study.
Li ZW; Zhang M; Yang YJ; Zhou ZJ; Liu YL; Li H; Bao B; Diao JD; Wang DW
PeerJ; 2020; 8():e8512. PubMed ID: 32117621
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiation therapy for older women with early-stage breast cancer: a propensity-matched SEER analysis.
Wu N; Tan Q; Su X; Yuan Y; Hou L; Li J
Clin Transl Oncol; 2023 Feb; 25(2):523-534. PubMed ID: 36227413
[TBL] [Abstract][Full Text] [Related]
19. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
Wang X; Liang N; Tian T; Zhang J; Hu P
Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
[No Abstract] [Full Text] [Related]
20. Postmastectomy radiation therapy can improve survival for breast cancer patients with 1-3 positive axillary lymph nodes: a retrospective cohort study using the SEER database.
Yang J; Zhang X; Ye Y; Lin Y; Yang Q; Cai H
Transl Cancer Res; 2021 May; 10(5):1984-2001. PubMed ID: 35116521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]